Table 4.
Laboratory Findings in 249 Discharged COVID-19 Patients in the Third People's Hospital of Shenzhen until February 24, 2020
| Variables | COVID-19 Patients |
p-value | ||
|---|---|---|---|---|
| Total (N = 249) | ≤20 days (n = 121) | >20 days (n = 128) | ||
| WBC (×109/L) | 4.63 (3.79–5.72) | 4.71 (4.06–5.83) | 4.54 (3.58–5.71) | >0.99 |
| LYM (×109/L) | 1.33 (1–1.77) | 1.5 (1.12–1.95) | 1.22 (0.98–1.63) | 0.054 |
| NEU (×109/L) | 2.58 (1.98–3.49) | 2.58 (2.03–3.48) | 2.58 (1.98–3.50) | >0.99 |
| HGB (g/L) | 137 (128–148) | 137 (127–147) | 138 (130–148) | >0.99 |
| PLT (×109/L) | 187 (150–227) | 197 (163–244) | 174 (146–204) | 0.012 |
| CD4+ cell count | 550 (414–746) | 618 (453–841) | 519 (377–658) | 0.14 |
| CD8+ cell count | 368 (234–526) | 429 (281–585) | 335 (218–465) | 0.078 |
| CD4+/CD8+ | 1.55 (1.12–2.03) | 1.55 (1.11–1.92) | 1.54 (1.19–2.17) | >0.99 |
| D-DIC (μg/mL) | 0.34 (0.24–0.50) | 0.31 (0.22–0.44) | 0.36 (0.26–0.54) | 0.96 |
| ALT (U/L) | 21.4 (15.1–30.625) | 20 (14.85–32) | 23 (16–30) | >0.99 |
| AST (U/L) | 27 (21–34) | 26 (20–33) | 28 (22–35) | >0.99 |
| K (mmol/L) | 3.90 (3.65–4.16) | 3.94 (3.66–4.17) | 3.89 (3.63–4.15) | >0.99 |
| Na (mmol/L) | 138.5 (136.8–139.7) | 138.7 (137.225–139.7) | 138 (136.1–139.7) | >0.99 |
| Cr (μmol/L) | 64 (52–77) | 62 (49–75) | 64 (54–79) | >0.99 |
| eGFR (mL/min) | 106.58 (94.43–118.12) | 111.11 (99.43–122.05) | 103.56 (92.53–115.10) | <0.01 |
| CK (U/L) | 67 (51–104) | 66 (54–93) | 76 (49–114) | >0.99 |
| LDH (U/L) | 223 (174–406) | 207 (165–384) | 234 (181–429) | >0.99 |
| MYO (ng/mL) | 36.85 (28.59–58.06) | 31.67 (25.30–46.80) | 42.73 (32.29–68.32) | 0.024 |
| BNP (pg/mL) | 1.94 (0.86–8.28) | 1.84 (1.1–3.078) | 4.32 (0.59–12.39) | >0.99 |
| TnI (μg/L) | <0.006 | <0.006 | <0.006 | >0.99 |
| TG (mmol/L) | 0.85 (0.69–1.23) | 0.77 (0.66–1.13) | 1.0 (0.77–1.37) | 0.87 |
| LDL (mmol/L) | 2.27 (1.94–2.82) | 2.23 (1.89–2.77) | 2.32 (1.99–2.86) | >0.99 |
| HDL (mmol/L) | 1.21 (1.00–1.41) | 1.25 (1.00–1.49) | 1.16 (1.01–1.35) | >0.99 |
| CHOL (mmol/L) | 3.96 (3.48–4.64) | 3.87 (3.45–4.58) | 3.96 (3.52–4.72) | >0.99 |
| PCT (ng/mL) | 0.038 (0.025–0.059) | 0.037 (0.025–0.059) | 0.039 (0.026–0.058) | >0.99 |
| CRP (mg/L) | 8.6 (2.5–21.6) | 6.7 (2.5–18.2) | 11.7 (3.2–25.7) | 0.22 |
| IL-6 (pg/mL) | 10.76 (4.54–19.07) | 7.76 (3.44–16.73) | 13.54 (6.90–23.51) | 0.044 |
| ESR (mm/h) | 25 (13–44) | 23 (12–40) | 27 (15–48) | >0.99 |
All laboratory values are in the form of medians(interquartile range). p values indicate differences between mild-moderate and severe-critical patients. p < 0.05 was considered statistically significant.
WBC, white blood cells; LYM, lymphocytes; NEU, neutrophils; HGB, hemoglobin; PLT, platelets; CD4+, CD4+ T lymphocyte; CD8+, CD8+ T lymphocyte; D-DIC, D-dimer; ALT, alanine aminotransferase; AST, aspartate aminotransferase; K, potassium; Na, sodium; Cr, chromium; eGFR, estimated glomerular filtration rate; CK, creatine kinase; MYO, myoglobin; BNP, brain natriuretic peptide; TnI, troponin I; LDH, lactate dehydrogenase; TG, triglyceride; LDL, low-density lipoprotein; HDL, high-density lipoprotein; CHOL, cholesterol; PCT, procalcitonin; CRP, C-reactive protein; IL-6, interleukin-6; ESR, erythrocyte sedimentation rate.